Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia

Jatinder K. Lamba; Xueyuan Cao; Susana C. Raimondi; Roya Rafiee; James R. Downing; Lei Shi; Tanja Gruber; Raul C. Ribeiro; Jeffrey E. Rubnitz; Stanley B. Pounds

doi:10.18632/oncotarget.25792

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia

PDF | How to cite

Oncotarget. 2018; 9:30473-30473. https://doi.org/10.18632/oncotarget.25792

Metrics: PDF 1700 views | ?

Jatinder K. Lamba¹, Xueyuan Cao², Susana C. Raimondi³, Roya Rafiee¹, James R. Downing³, Lei Shi², Tanja Gruber⁴, Raul C. Ribeiro⁴, Jeffrey E. Rubnitz⁴ and Stanley B. Pounds²

¹ Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA
² Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN, USA
³ Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, USA
⁴ Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN, USA

Published: July 13, 2018

This article has been corrected: The correctly spelled author name is given below:

Lei Shi

Original article: Oncotarget. 2018; 9:26711-26723. DOI: https://doi.org/10.18632/oncotarget.25475.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25792

Publication Alerts

Corrections:

Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia